期刊文献+

氯沙坦减轻自发性高血压大鼠主动脉重构及其机制(英文) 被引量:2

Losartan attenuates vascular remodeling of the aorta in spontaneously hypertensive rats and the underlying mechanism
暂未订购
导出
摘要 目的:观察氯沙坦治疗对自发性高血压大鼠(SHR)主动脉重构及p22phox表达的影响。方法:36只12周龄SHR连续灌胃给予氯沙坦,剂量分别为0,15,30 mg/(kg.d),每组12只;另取12只WKY大鼠作为非高血压对照组。每周测定尾动脉压。8周后检测主动脉病理结构、血浆过氧化氢(H2O2)水平、过氧化氢酶(CAT)活力、血浆血管紧张素Ⅱ(Ang II)水平、主动脉p22phox的表达。结果:SHR主动脉血管壁明显增厚,尾动脉压、血浆H2O2和AngⅡ水平及主动脉p22phox的表达均显著增高,而血浆CAT活力明显下降;应用氯沙坦治疗在降低血压的同时,可改善SHRL主动脉结构,降低血浆H2O2水平和主动脉p22phox的表达,升高血浆AngⅡ水平及和CAT活力。结论:SHR主动脉血管重构涉及氧化应激,氯沙坦可改善血管重构,其机制与下调p22phox表达、抑制氧化应激有关。 Objective To determine the effect of losartan on vascular remodeling and the underlying mechanism in spontaneously hypertensive rats(SHR).Methods SHR of 12 weeks old were given losartan orally [0,15,30 mg/(kg·d),n=12].The tail arterial pressure was measured every week.Eight weeks later,the pathological changes and p22phox expression in the thoracic aorta,the activity of catalase(CAT),the contents of H2O2 and AngⅡ in the plasma were evaluated.Results Blood pressure was increased in the SHR accompanied by the thickened wall and increased p22phox expression in the thoracic aorta.The plasma levels of H2O2 and AngⅡwere elevated while the CAT level was decreased in the SHR.Administration of losartan reversed the thickened wall and increased the CAT activity concomitantly with the decreased plasma levels of H2O2 and p22phox expression in the SHR.The plasma level of AngⅡincreased after the losartan treatment.Conclusion Oxidative stress induces the vascular remodeling of the aorta in the SHR.Losartan can reverse the vascular remodeling through down-regulating p22phox expression and inhibiting the oxidative stress.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2010年第8期807-813,共7页 Journal of Central South University :Medical Science
关键词 氧化应激 血管重构 自发性高血压大鼠 氯沙坦 oxidative stress vascular remodeling spontaneously hypertensive rats losartan
  • 相关文献

参考文献22

  • 1Intengan H D,Schiffrin E L.Vascular remodeling in hypertension:roles of apoptosis,inflammation,and fibrosis[J].Hypertension,2001,38(3Pt 2):581-587.
  • 2Fortuo A,San José G,Moreno M U,et al.Oxidative stress and vascular remodeling[J].Exp Physiol,2005,90(4):457-462.
  • 3Touyz R M.Reactive oxygen spercies in vascular biology:role in arterial hypertension[J].Expert Rev Cardiovasc Ther,2003,1(1):91-106.
  • 4Paravicini T M,Touyz R M.Redox signaling in hypertension[J].Cardiovasc Res, 2006,71(2):247-258.
  • 5Droge W.Free radicals in the physiological control of cell function[J].Physiol Rev,2002,82(1):47-95.
  • 6Modlinger P,Chabrashvili T,Gill P S,et al.RNA silencing in vivo reveals role of p22phox in rat angiotensin slow pressor response[J].Hypertension,2006,47(2):238-244.
  • 7夏珂,李岱,赵震宇,杨天崙.ADMA对自发性高血压大鼠血小板聚集的影响及氯沙坦的干预作用[J].中南大学学报(医学版),2006,31(5):645-649. 被引量:3
  • 8谢启应,孙泽琳,陈美芳,杨天崙.氯沙坦保护ox-LDL诱导的内皮细胞损伤与ADMA的关系[J].中南大学学报(医学版),2006,31(1):66-69. 被引量:8
  • 9Thannickal V J,Fanburg B L.Reactive oxygen species in cell signaling[J].Am J Physiol Lung Cell Mol Physiol,2000,279(6):L1005-L1028.
  • 10Zafari A M,Ushio-Fukai M,Akers M,et al.Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy[J].Hypertension,1998,32(3):488-495.

二级参考文献23

  • 1Jun-linJIAN De-jianJIANG Yu-haiTANG Nian-shengLI Han-wuDENG Yuan-jianLI.Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor[J].Acta Pharmacologica Sinica,2004,25(7):893-901. 被引量:7
  • 2姜德建,江俊麟,谭桂山,戴忠,徐康平,刘桂珍,李元建.川东獐牙菜素A保护溶血性磷脂酰胆碱诱导的内皮细胞损伤[J].中南药学,2003,1(2):75-79. 被引量:6
  • 3de Graaf J C,Banga J D,Moncada S,et al.Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions[J].Circulation,1992,85(6):2284-2290.
  • 4Cooke J P.Does ADMA cause endothelial dysfunction?[J].Arterioscler Thromb Vasc Biol,2000,20(9):2032-2037.
  • 5Monton M,Jimenez A,Nunez A.Comparative effects of angiotensin Ⅱ AT-1-type receptor antagonists in vitro on human platelet activation[J].J Cardiovasc Pharmacol,2000,35(6):906-913.
  • 6Furchgott R F,Zawadzki J V.The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine[J].Nature,1980,27;288(5789):373-376.
  • 7Radomski M W,Palmer R M,Moncada S.An L-arginine/nitric oxide pathway present in human platelets regulates aggregation[J].Proc Natl Acad Sci USA,1990,87(13):5193-5197.
  • 8Vallance P,Leone A,Calver A,et al.Endogenous dimethyl-arginine as an inhibitor of nitric oxide synthesis[J].J Cardiovasc Pharmaco,1992,20(Suppl 12):S60-62.
  • 9Boger R H,Vallance P,Cooke J P,et al.Asymmetric dimethylarginine (ADMA):a key regulator of nitric oxide synthase[J].Atherosclerosis,2003,4(4):1-3.
  • 10Lundman P,Eriksson M J,Stuhlinger M,et al.Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine[J].J Am Coll Cardiol,2001,38(1):111-116.

共引文献9

同被引文献14

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部